- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06570525
Intervention Evaluation WEH (Women Who Have Experienced Homelessness)
Improving Traumatic Stress in Women Who Have Experienced Homelessness: Evaluation of a Stakeholder Engaged Intervention
Homelessness and associated traumas disproportionately impact women relative to men. Women who have experienced homelessness (WEH) universally face traumatic stress, often before becoming homeless and while experiencing homelessness.
For WEH who are incarcerated, additional trauma may occur while in correctional settings. Black WEH are disproportionately impacted by trauma, homelessness, and incarceration, as is related to structural and individual racism and discrimination (racial trauma).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Phase
- Phase 1
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- self-identifies as a woman
- ≥18 years of age
- history of homelessness or currently experiencing homelessness (HRSA criteria)
- affected by trauma-related distress (≥1 on Life Events Checklist + PTSD Checklist for DSM-5 ≥28)
- at least 75% of the sample must self-identify as Black/African American
Exclusion Criteria:
• impaired decisional capacity (UC-San Diego Brief Assessment ≤14.5)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: NurseNET-Narrative Exposure Therapy
Nurse-Delivered Narrative Exposure Therapy (NurseNET).
Narrative Exposure Therapy (NET) is a brief, low-cost, trauma-focused treatment modality that is effective in treating mobile populations with complex PTSD.
In NurseNET, NET is facilitated by a clinically experienced nurse, while peers/program support specialists offer scaffolded support, fostering trust, engagement, and retention.
NurseNET begins with administration of a "diagnostic battery" and psychoeducation.
Then, in subsequent NurseNET sessions, using gradual imaginative exposure, the nurse guides the participant to verbally express and re-frame their personal trauma narratives to shift unhelpful beliefs/symptoms around trauma.
NurseNET utilizes a racism-conscious approach to create relational spaces in which narratives of WEH are positioned to challenge dominant social narratives.
Each NurseNET session offers a brief soulfulness-based stress reduction activity to prompt emotional/affective grounding.
|
Nurse-Delivered Narrative Exposure Therapy (NurseNET).
Narrative Exposure Therapy (NET) is a brief, low-cost, trauma-focused treatment modality that is effective in treating mobile populations with complex PTSD.
In NurseNET, NET is facilitated by a clinically experienced nurse, while peers/program support specialists offer scaffolded support, fostering trust, engagement, and retention.
NurseNET begins with administration of a "diagnostic battery" and psychoeducation.
Then, in subsequent NurseNET sessions, using gradual imaginative exposure, the nurse guides the participant to verbally express and re-frame their personal trauma narratives to shift unhelpful beliefs/symptoms around trauma.
NurseNET utilizes a racism-conscious approach to create relational spaces in which narratives of WEH are positioned to challenge dominant social narratives.
Each NurseNET session offers a brief soulfulness-based stress reduction activity to prompt emotional/affective grounding.
|
|
Active Comparator: PAL: Peer Active Listening
Peer Active Listening (PAL).
In the PAL active comparator/control, peers/program support specialists meet individually with participants in "active listening sessions", along the same visit sequence as NurseNET.
During PAL sessions, peers/program support specialists allow participants to set each conversational agenda while practicing the tenets of active listening, including attending to body language, paraphrasing the participant's verbal expressions, reflecting feelings, and using tactful repetition.
PAL sessions are not intended to center on topics of trauma, but rather designed to offer a supportive relationship (attentional control).
|
Peer Active Listening (PAL).
In the PAL active comparator/control, peers/program support specialists meet individually with participants in "active listening sessions", along the same visit sequence as NurseNET.
During PAL sessions, peers/program support specialists allow participants to set each conversational agenda while practicing the tenets of active listening, including attending to body language, paraphrasing the participant's verbal expressions, reflecting feelings, and using tactful repetition.
PAL sessions are not intended to center on topics of trauma, but rather designed to offer a supportive relationship (attentional control).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Posttraumatic Stress Disorder (PTSD) symptoms
Time Frame: Eligibility Screening; Pre-/Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 (PCL-5).
Higher score = worse outcome.
Range: 0-80.
|
Eligibility Screening; Pre-/Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Patient Depression Questionnaire (PHQ-9).
Higher score = worse outcome.
Range: 0-27.
|
Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
|
Anxiety
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Generalized Anxiety Disorder (GAD-7).
Higher score = worse outcome.
Range: 0-21.
|
Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
|
Sleep symptoms
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Regensburg Insomnia Scale (RIS).
Higher score = worse outcome.
Range: 0-40.
|
Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
|
Somatization
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Somatic Symptoms Scale (SSS-8).
Higher score = worse outcome.
Range: 0-32.
|
Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
|
Substance use
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) tool.
TAPS-1, is a four-item screening that asks about substance use in the past 12 months.
|
Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Healthcare access
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4)
|
Barriers to Access to Care Evaluation Scale (BACE).
Higher score = worse outcome (greater barrier to seeking treatment).
Range: 0-90.
30-items, 12-item subscale measures the extent to which stigma and discrimination are barriers to care.
|
Pre-Assessment (week 0), Post-Assessment (week 4)
|
|
Perceived social support
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
Multidimensional Scale of Perceived Social Support Scale (MSPSS).
Higher score = better.
Range: 0-60.
|
Pre-Assessment (week 0), Post-Assessment (week 4); Follow-up Assessments (weeks 10 and 16)
|
|
Discrimination
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4)
|
Everyday/Major Experiences of Discrimination Scale (EDS/MDS).
This measure contains nine elements that assess the participant's perception of major experiences of discrimination, followed by a follow-up question about what the person believes was the reason for that discrimination (no numeric scoring).
|
Pre-Assessment (week 0), Post-Assessment (week 4)
|
|
Racial trauma
Time Frame: Pre-Assessment (week 0), Post-Assessment (week 4)
|
Racial Trauma Scale (RTS) (short form research version).
Higher score = worse.
Range: 9-36.
|
Pre-Assessment (week 0), Post-Assessment (week 4)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kirsten A Dickins, PhD, FNP-C, Rush University Medical Center
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 24061301
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
Sofie FolkeAarhus University Hospital; Copenhagen Trial Unit, Center for Clinical Intervention... and other collaboratorsNot yet recruiting
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
ARQ National Psychotrauma CentreLeiden University Medical CenterEnrolling by invitationPosttraumatic Stress Disorder (PTSD)Netherlands
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompleted
Clinical Trials on NurseNET
-
Rush University Medical CenterRecruiting